Roles of exogenous bioactive peptides in obesity and obesity-related diseases: A review

Exogenous bioactive peptides (eBAPs) are short amino acid peptides that are released through enzymatic hydrolysis. These peptides are derived from various sources such as oysters, soybeans, eggs, and other foods. The eBAPs exhibit a range of biological activities. Recent studies have shown that eBAPs have the potential to alleviate and mitigate obesity and its associated metabolic disorders. These disorders include cardiovascular diseases, hypertension, insulin resistance, and type 2 diabetes. In the present review, we have summarised the biological activities and production of eBAPs and their physiological regulatory functions in relation to obesity and obesity-related diseases. These findings would provide new insights and encourage further in-depth research on eBAPs.